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Environmental xenobiotics are suspected to
play a causative role in alterations ofsexual
development in wildlife species (1). Some
pesticides, such as DDT and chlordecone
(Kepone), were found to have estrogenic
properties long after they were released into
the environment (2-4). The use of these
pesticides has since been restricted in the
United States. It should be noted that the
estrogenic activity of chemicals cannot be
deduced solely from their molecular struc-
ture; therefore, it is uncertain whether pes-
ticides currently used are estrogenic. To
explore this possibility, we tested a group
ofpesticides using a bioassay, the E-screen
test, that measures the proliferative effect of
estrogens on their target cells (human
breast cancer MCF7 cells) (5,6).
Materials and Methods
Human breast cancer estrogen-sensitive
MCF7 cells were obtained from the
Michigan Cancer Foundation (Detroit,
Michigan) (7). For routine maintenance,
cells were grown in Dulbecco's modifica-
tion of Eagle's Medium (DME; Gibco,
Grand Island, New York) supplemented
with 5% fetal bovine serum (FBS;
Hyclone, Logan, Utah) in an atmosphere
of 5% C02/95% air under saturating
humidity at 37°C.
We prepared plasma-derived human
serum from outdated plasma by adding
calcium chloride to a final concentration of
30 mM to facilitate clot formation. Blood-
derived serum was obtained using blood
from healthy adult volunteers; we allowed
blood to clot in glass centrifuge tubes for
2-4 hr to obtain serum. Plasma- and
blood-derived serum were clarified by cen-
trifugation (3000 rpm x 10 min), heat-
inactivated (56°C for 30 min), centrifuged,
and stored in glass tubes at -20°C until
use.
Charcoal (Norit A, acid washed, Sigma
Chemical Co, St. Louis, Missouri) was
washed twice with cold sterile water imme-
diately before use. A 5% charcoal-0.5%
dextran T70 (Pharmacia-LKB, Uppsala,
Sweden) suspension was prepared. We cen-
trifuged charcoal-dextran suspension
aliquots of a volume similar to the serum
aliquots to be processed at 2500 rpm for
10 min. Supernatants were aspirated, and
serum aliquots were mixed with the char-
coal pellets. This charcoal-serum mixture
was maintained in suspension by rolling at
4 cycles/min at 37°C for 1 hr. This suspen-
sion was centrifuged at 2500 rpm for 20
min. We then filtered the supernatant
through a 0.45-pm Nalgene filter. More
than 99% of serum sex steroids were
removed by this treatment (8). CD sera
were stored at -200C until needed; samples
kept for 1 year in the freezer maintained
their inhibitory properties toward the pro-
liferation of human estrogen-sensitive
breast tumor MCF7 cells; plasma- and
blood-derived sera were equally effective.
Cloned MCF7 cells were trypsinized
and plated into 12-well plates (Costar,
Cambridge, Massachusetts) at initial con-
centrations of 20,000 cells per well (5,6).
We allowed cells to attach for 24 hr; then
we removed seeding medium (5% FBS in
DME) and replaced it with the experimen-
tal medium (5% charcoal-dextran stripped
human serum supplemented to phenol
red-free DME). To this medium, a range
of concentrations of the test compound
was added. The bioassay was terminated
on day 6 (late exponential phase) by
removing the media from the wells, adding
a cell lysing solution [10% ethylhexadecyl-
dimethylammonium bromide (Eastman
Kodak Co., Rochester, NewYork) in 0.5%
Triton X100, 2 mM MgCl2, 15 mM
NaCl, 5 mM phosphate buffer pH 7.4],
and counting the nuclei in a Coulter
Counter Apparatus (model ZM; Coulter
Electronics, Hialeah, Florida).
Estradiol-17f was obtained from
Calbiochem (Richmond, California).
Toxaphene, technical grade, and endosul-
fan, technical grade, were obtained from
Chem Services (West Chester, Penn-
sylvania). Endosulfan a and f9 isomers,
o,p'-DDT, p,p'-DDT, p,p'-DDD, p,p'-
DDE, 2,3,4,5 tetrachlorobiphenyl,
2,2',3,3',6,6'-hexachlorobiphenyl,
methoxychlor, and dieldrin were from
Ultra Scientific (North Kingstown, Rhode
Island). Estradiol was stored as a 1 mM
stock solution in ethanol at -20'C.
Pesticides were dissolved in ethanol to a
final concentration of 10 mM, except
endosulfan mixed isomers, dieldrin and
toxaphene which were dissolved in
dimethyl sulfoxide (DMSO); they were all
diluted to desired concentrations in phenol
red-free DME immediately before using.
The final solvent concentration in culture
medium did not exceed 0.1%; this con-
centration did not affect cell yields.
Results are expressed as means ± SEs.
We repeated proliferation yield experi-
ments conducted in duplicate wells a mini-
mum of five times. Mean cell numbers
from each experiment were normalized to
the steroid-free control (100%) to correct
for differences in the initial plating densi-
ty. We assessed differences between the
diverse steroid treatment groups by analy-
sis ofvariance and student Newman-Keuls
tests. Ap-value of <0.05 were regarded as
significant.
Results
The E-screen test is based on the following
premises: a human serum-borne molecule
specifically inhibits the proliferation of
human estrogen-sensitive cells (8,9); and
estrogens induce cell proliferation by neu-
tralizing this inhibitory effect (8,9).
Nonestrogenic steroids and growth factors
do not abolish the proliferative inhibition
by human serum (8-10). The assay com-
pares the cell yield achieved by similar cell
inocula harvested simultaneously during
the exponential phase of proliferation
(5,6).
The estrogenic activity of xenobiotics
was assessed by 1) determining the relative
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proliferative potency (RPP); this is the
ratio between the minimal concentration
of estradiol needed for maximal cell yield
at 6 days and the dose of the test com-
pound to achieve a comparable prolifera-
tive effect, and 2) measuring the relative
proliferative effect (RPE); this is 1OOx the
ratio between the highest cell yield
obtained with the chemical and with estra-
diol. The RPE indicates whether the com-
pound being tested induces a proliferative
response quantitatively similar to the one
obtained with estradiol; that is, ifit is a full
agonist (RPE = 100), or a proliferative
yield significantly lower than the one
obtained with estradiol; that is, if it is a
partial agonist.
o,p'-DDT and chlordecone are pesti-
cides with well-documented estrogenic
activity in several vertebrate species
(2-4, 11). Their RPP measured by the E-
screen test was 0.0001% that of estradiol
(Table 1); although clearly estrogenic, the
cell yield obtained with these chemicals
was somewhat lower than that ofestradiol
(o,p'-DDT, RPE = 86%; chlordecone,
RPE = 84%). Technical grade endosulfan
and a and fI endosulfan isomers were
estrogenic at concentrations of 10-25 pM
(Fig. 1); higher concentrations were cyto-
toxic. It should be noted that the RPE of
all ofthese chemicals is lower than that of
estradiol (endosulfan mixed isomers, RPE
= 81%; a isomer, RPE = 77%; 11 isomer,
RPE = 78%); the fact that these com-
pounds have toxic effects at concentrations
one order of magnitude higher than those
needed to evoke a proliferative response
precluded assessing whether higher con-
centrations would attain full estrogenic
activity. Dieldrin and toxaphene were
estrogenic at 10 pM (Fig. 2); higher con-
centrations were toxic. The RPE of these
compounds were lower than those ofendo-
sulfan (dieldrin, RPE = 55%; toxaphene,
RPE = 52%; Table 1).
Humans and wildlife are simultaneous-
ly exposed to a variety ofchemicals (1,12.
Residues of diverse estrogenic xenobiotics
coexist in fat and body fluids of exposed
individuals (12); hence, it is likely that
they may become bioavailable. At such
time, these xenobiotics may act cumula-
tively; that is, when each ofthem is present
at levels lower than those needed to express
overt estrogenicity. To explore this con-
cept, we administered a mixture of 10
estrogenic chemicals to MCF7 cells at con-
centrations 10-fold lower than those
required to produce an estrogenic effect
when given alone; the resulting cumulative
effect is illustrated in Figure 3. This com-
bination resulted in a significant prolifera-
tive effect.
Discussion
Several xenobiotics such as polychlorinated
biphenyls, chlordecone, and methoxychlor,
were shown to be estrogenic in animal
models; however, their lower estrogenic
potency was interpreted as having none or
weaker deleterious effects on humans
exposed through the food chain.
Occupational exposure to chlordecone, on
the other hand, resulted in overt estro-
genicity manifested as oligospermia and
sterility (4). Because most organochlorine
contaminants bioacummulate and remain
preferentially in fat, concern about their
long-term effects has been raised in the
public health community. Recent reports
suggest that these chemicals are interfering
with the reproductive success of wildlife
(13). In addition, humans may also be at
risk. For example, an epidemiological
study showed a positive correlation
between breast cancer and serum levels of
DDE, a DDT metabolite (14). This find-
ing suggests, but does not prove, that
organochlorines may be an important etio-
logical factor on breast cancer, probably
because of their estrogenicity. In addition,
it has been postulated that the increased
incidence ofcryptorchidism, testicular and
prostate cancer, as well as the decrease in
human semen quality over the last 50
years, may be due to environmental estro-
gens (15,16). Also, other synthetic estro-
Table 1. Estrogenic effect ofpesticides8
Compound Concentration PE RPE (%) RPP (%)
Estradiol 10pM 3.68 100 100
o,p'-DDT 10 pM 3.17 86.14 0.0001
Chlordecone 10 PM 3.09 84.00 0.0001
b Endosulfan 10 pM 2.99 81.25 0.0001
DDTb 10 pM 2.93 79.61 0.0001
Endosulfan 1 10 PM 2.88 78.26 0.0001
Endosulfan a 10 pM 2.84 77.17 0.0001
Dieldrin 10 pM 2.02 54.89 0.0001
Toxaphene 10 pM 1.91 51.90 0.0001
"Concentration' denotesthe dose atwhich estrogenic effect is detected. PE; proliferative efficiency,
measuresthe ratio between the highest cell number in the presence and in the absence of estrogen.
RPE, relative proliferative efficiency; measures the ratio between the maximal cellyield achieved bythe
xenobiotic andthatof estradiol. RPP, relative proliferative potency; measures the ratio between the dose
ofxenobiotic andthat ofestradiol needed to achieve a proliferative effect. UTechnical grade.
gens such as diethylstilbestrol, used for a
perceived therapeutic purpose, induced
reproductive tract malignancies in the off-
spring ofexposed women (17-19).
The present study shows for the first
time that the pesticides dieldrin and
toxaphene, which have been restricted
from use in the United States since 1974
and 1982, respectively, are estrogenic
(Table 1). These compounds are highly
lipophilic and bioaccumulate through
ecosystems; they are still found in wildlife,
coincident with signs of reproductive
impairment. Toxaphene is a main airborne
pollutant in North America; its residues
appear in regions where it has never been
used, like the Arctic and Scandinavia (20).
Toxaphene accumulates in soil (21), bioac-
cumulates preferentially in fat where it per-
sists (20), has been linked to reproductive
damage in seals (22), and is present in
Arctic and Baltic salmon muscle fat at con-
centrations of 700-7,000 ppb (22); this
concentration is well within those produc-
ing estrogenic effects in human breast
MCF7 cells (10 pM = 4800 ppb; Fig. 2).
Endosulfan was first introduced in
1954; it is currently used for agricultural
purposes in the United States and other
countries (23). The worldwide production
ofthis chemical was estimated to be 10000
metric tons in 1984 (24); recent produc-
tion data were not available. In a study
conducted in Southern Ontario, Canada,
78% of the milk samples analyzed con-
tained 1-10 ppb (2-5). The a isomer was
detected in leafy vegetables up to a level of
93 ppb; the fI isomer was detected up to a
level of 150 ppb. We now report prolifera-
tive, estrogenlike effects in MCF7 cells at
doses of 10 pM (4060 ppb). Endosulfan
produced testicular atrophy in male rats
fed a diet containing 10 ppm (26,27); it
also lowered gonadotrophin and testos-
terone plasma levels (28). These results are
consistent with its estrogenicity revealed by
the E-screen test.
The estrogenic potency of dieldrin,
toxaphene, and endosulfan as measured by
the E-screen test was comparable to that of
DDT and chlordecone, and six orders of
magnitude lower than that of estradiol
(Figs. 1, 2) (6). Studies carried out in rats
showed that the estrogenic effect of
chlordecone measured as increased uterine
wet weight is qualitatively comparable to
that of estradiol (11); however, to achieve
this effect a 1000- to 5000 fold higher dose
of chlordecone than that of estradiol was
required (11). This discrepancy may be
due to the rapid metabolism of estradiol
and the persistence and bioaccumulation
of chlordecone in vivo. Differences
between results in culture and in live ani-
mals reflect the different parameters used
as a measure of estrogenicity. On one
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Figure 1. Proliferative activity of (A) estradiol, (B) endosulfan a, (C) endosulfan X, and (D) endosulfan,
technical grade. *Significant differences from hormoneless control (p<0.01).
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Figure 2. Proliferative activity of (A) estradiol, (B) toxaphene, (C) dieldrin, (D) DDT mixed isomers, and (E)
o,p'-DDT. *Significant differences from hormoneless control (p<O.O1).
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Figure 3. Proliferative activity of(A) hormoneless control, (B) 10 pM endosulfan B, (1) 1 pM endosulfan X,
(2) 1 pM endosulfan a, (3)1 pM toxaphene, (4)1 pM dieldrin, (5) 1 pM 2,3,4,5-tetrachlorobiphenyl, (6)1 pM
p,p'-DDT, (7) 1 pM 2,2',3,3',6,6'-hexachlorobiphenyl, (8) 1 pM p,p'-DDD, (9) 1 pM p,p'-DDE, (10) 1 pM
methoxychlor, and (C) mixture of the 10 chemicals indicated as 1-10, each at 1 pM. *Significant differ-
encesfrom hormoneless control (p<O.O1).
hand, the rodent assay measures the
increase ofuterine wet weight; this is only
a crude estimate ofestrogen action because
it represents the combination ofthree sepa-
rate effects, namely, water imbibition,
hypertrophy, which is also produced by
estrogen antagonists, and hyperplasia (29).
The human E-screen cell bioassay, on the
other hand, measures cell proliferation; this
is the sole parameter acknowledged to be
the hallmark of estrogen action (30). In
addition, whereas the human E-screen test
measures direct estrogenicity at the target-
cell level, animal studies are a composite of
several pharmacokinetic parameters such as
metabolism and clearance.
Environmental estrogens may act cumu-
latively (Fig. 3) and with endogenous estro-
gens to disrupt the endocrine system of
exposed wildlife and humans. The data in
Figure 3 suggest that measuring the total
estrogenic burden due to environmental
contaminants may be more meaningful
than assessing exposure by measuring the
levels of each of the known xenoestrogens.
The E-screen test may be used to this end
once a protocol is developed to separate
environmental estrogens from endogenous
ones. As a preventive approach, the E-
screen test may be used to screen chemicals
for their estrogenicity before they are
released into the environment.
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